Recommendation Statement News Today

MorphoSys AG / Key word(s): PersonnelAd hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO06-Jun-2024 / 22:19 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service...

Investegate announcements from EQS-Adhoc: Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO

EQSAdhoc MorphoSys AG Key word Personnel Ad hoc Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO 06Jun2024 2219 CETCEST Disclosure of

EQSAdhoc MorphoSys AG Key word Personnel Ad hoc Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO 06Jun2024 2219 CETCEST Disclosure of

Akili to operate as wholly owned subsidiary of Virtual Therapeutics ...

Investegate announcements from PRTC's Akili Enters Into Merger Agreement

/PRNewswire/ -- On 24 April, 2024, K1 made an announcement pursuant to Rule 2.7 of the Irish Takeover Rules (the "Rule 2.7 Announcement") of a firm intention...

Extension of Deadline in Accordance with Rule 24.1(b) of the Irish Takeover Rules NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM

American Strategic Investment Co. announced today that it has filed with the Securities and Exchange Commission a Solicitation/Recommendation Statement on Schedule 14D-9 and Letter to Stockholders...

Purchase Price of $8.50 per Share in Cash Transaction Valued at $950 Million ...